Jpmorgan Chase & CO Tg Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 720,798 shares of TGTX stock, worth $25.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
720,798
Previous 450,512 60.0%
Holding current value
$25.3 Million
Previous $8.01 Million 110.37%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$17.21 - $25.28 $4.65 Million - $6.83 Million
270,286 Added 60.0%
720,798 $16.9 Million
Q2 2024

Aug 12, 2024
BUY
$13.32 - $19.19 $1.14 Million - $1.65 Million
85,837 Added 23.54%
450,512 $8.01 Million
Q1 2024

May 10, 2024
BUY
$13.02 - $21.3 $1.27 Million - $2.09 Million
97,907 Added 36.7%
364,675 $5.55 Million
Q4 2023

Feb 12, 2024
BUY
$6.68 - $18.81 $415,616 - $1.17 Million
62,218 Added 30.42%
266,768 $4.56 Million
Q3 2023

Nov 14, 2023
SELL
$8.36 - $26.5 $588,711 - $1.87 Million
-70,420 Reduced 25.61%
204,550 $1.71 Million
Q2 2023

Aug 11, 2023
SELL
$15.48 - $35.0 $2.01 Million - $4.54 Million
-129,778 Reduced 32.06%
274,970 $6.83 Million
Q1 2023

May 18, 2023
BUY
$10.23 - $19.34 $1.74 Million - $3.28 Million
169,664 Added 72.17%
404,748 $6.09 Million
Q1 2023

May 11, 2023
SELL
$10.23 - $19.34 $539,448 - $1.02 Million
-52,732 Reduced 18.32%
235,084 $3.54 Million
Q4 2022

Feb 13, 2023
SELL
$5.01 - $11.83 $4,719 - $11,143
-942 Reduced 0.33%
287,816 $3.41 Million
Q3 2022

Nov 14, 2022
SELL
$4.57 - $8.4 $10,195 - $18,740
-2,231 Reduced 0.77%
288,758 $1.71 Million
Q2 2022

Aug 11, 2022
BUY
$3.74 - $10.66 $84,280 - $240,223
22,535 Added 8.39%
290,989 $1.24 Million
Q1 2022

May 11, 2022
BUY
$7.81 - $20.45 $65,158 - $170,614
8,343 Added 3.21%
268,454 $2.55 Million
Q4 2021

Feb 10, 2022
BUY
$15.2 - $35.51 $1.51 Million - $3.54 Million
99,635 Added 62.09%
260,111 $4.94 Million
Q3 2021

Nov 12, 2021
BUY
$21.78 - $40.45 $3.5 Million - $6.49 Million
160,476 New
160,476 $5.34 Million

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.09B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email